What Are Peptides?
Peptides are short chains of amino acids connected by peptide bonds. Research profiles distinguish each compound by identity, aliases, structure or formulation, biological targets, evidence type and source date so similarly named records are not treated as interchangeable.
Peptides and Research Compounds
The current catalogue is grouped below with a concise, compound-specific description. Profile links will be added individually as each complete research page is reviewed and published.
GLP-1 Peptides
- Cagrilintide (Cagri) — a peptide research entry commonly discussed in amylin-related receptor and peptide-signaling contexts.
- Cagrilintide + Semaglutide Blend (CagriSema) — cagrilintide + Semaglutide (CagriSema) is a named combination blend that brings together cagrilintide and semaglutide as separate peptide components.
- Retatrutide (Reta)Reviewed profile — a synthetic research peptide described in published literature as acting across GIP, GLP-1, and glucagon receptor systems.
- Semaglutide (Sema) — a peptide research entry commonly associated with GLP-1 receptor signaling literature.
- Tirzepatide (Tirz) — a peptide research entry commonly associated with combined GIP and GLP-1 receptor signaling literature.
Growth & Signaling
- CJC-1295 With Drug Affinity Complex (CJC-1295 DAC) — cJC-1295 DAC is a CJC-1295 peptide entry identified by its Drug Affinity Complex designation.
- CJC-1295 Without Drug Affinity Complex (CJC-1295 No DAC) — cJC-1295 No DAC is a distinct CJC-1295 No DAC catalogue entry that must remain separate from CJC-1295 with DAC.
- CJC-1295 Without Drug Affinity Complex + Ipamorelin Blend (CJC-1295 No DAC + Ipamorelin) — cJC-1295 No DAC + Ipamorelin is a named blend that should remain distinct from both CJC-1295 with DAC and single-ingredient peptide entries.
- Ipamorelin — a peptide research entry commonly associated with growth-hormone secretagogue literature.
- Long R3 Insulin-Like Growth Factor-1 (IGF-1 LR3) — iGF-1 LR3 is a long R3 insulin-like growth factor-1 analogue used in growth-factor signaling research contexts.
- Sermorelin Acetate — a peptide entry associated with growth-hormone-releasing hormone research contexts.
- Somatropin, 191-Amino-Acid Human Growth Hormone (HGH) — somatropin (HGH) is a 191-amino-acid human growth hormone entry identified as somatropin in the source record.
- Tesamorelin (Tesa) — a peptide entry commonly associated with growth-hormone-releasing hormone research contexts.
Repair & Structural
- Body Protection Compound-157 (BPC-157) — bPC-157 is a peptide entry commonly identified by the established BPC-157 designation.
- Body Protection Compound-157 + Thymosin Beta-4 + Glycyl-L-histidyl-L-lysine Copper(II) Complex + Lysine-Proline-Valine Blend (BPC-157 + TB-500 + GHK-Cu + KPV) — bPC-157 + TB-500 + GHK-Cu + KPV Blend is a multi-component peptide blend whose product identity is defined by the components named in the catalogue.
- Body Protection Compound-157 + Thymosin Beta-4 Blend (BPC-157 + TB-500) — bPC-157 + TB-500 Blend is a two-component peptide blend identified by the BPC-157 and TB-500 names supplied in the catalogue.
- Glycyl-L-histidyl-L-lysine Copper(II) Complex (GHK-Cu) — gHK-Cu is a copper-containing tripeptide complex identified by the established GHK-Cu abbreviation.
- Glycyl-L-histidyl-L-lysine Copper(II) Complex + Thymosin Beta-4 + Body Protection Compound-157 Blend (GHK-Cu + TB-500 + BPC-157) — gLOW Blend is a named blend containing the GHK-Cu, TB-500, and BPC-157 components stated in the catalogue.
- L-Alanyl-L-histidyl-L-lysine Copper(II) Complex (AHK-Cu) — aHK-Cu is a copper-containing tripeptide complex used in peptide-chemistry and coordination research contexts.
- Lysine-Proline-Valine (KPV) — kPV is a tripeptide identified by the Lysine-Proline-Valine sequence and KPV abbreviation.
- Thymosin Beta-4 (TB-500) — a peptide entry identified by the Thymosin Beta-4 and TB-500 names.
Neural & Immune
- Delta Sleep-Inducing Peptide (DSIP) — dSIP is a peptide identified as Delta Sleep-Inducing Peptide in historical neuropeptide literature.
- Selank — a synthetic peptide research entry commonly discussed in neuropeptide literature.
- Semax — a synthetic peptide research entry commonly discussed in neuropeptide literature.
- Vasoactive Intestinal Peptide (VIP) — a peptide identified by the established Vasoactive Intestinal Peptide and VIP names.
Cellular & Longevity
- Adamax — a catalogued research material whose public chemical identity is not established in the source record.
- AOD-9604 — a modified peptide analogue identified in the literature as Tyr-hGH(177–191), rather than the unmodified hGH fragment.
- Elamipretide (SS-31) — a mitochondria-targeted peptide identified by the Elamipretide and SS-31 names.
- Epithalon — a short peptide research entry commonly listed under the Epithalon name.
- Glutathione (GSH) — a tripeptide-derived compound widely recognized in redox and antioxidant-pathway research.
- Mitochondrial Open Reading Frame of the 12S rRNA Type-c (MOTS-c) — mOTS-c is a mitochondrial-derived peptide identified by the MOTS-c designation.
- Nicotinamide Adenine Dinucleotide, Oxidized Form (NAD+) — nAD+ is the oxidized form of nicotinamide adenine dinucleotide, a central cofactor in redox biology.
- Thymosin Alpha-1 (TA-1) — thymosin Alpha-1 (Tα1) is a peptide entry identified by the Thymosin Alpha-1 and Tα1 names.
Laboratory & Additional Research Products
- BAC Water (BA) — bAC Water is a laboratory supply listed as BAC Water (BA), with formulation details intentionally limited to the available product record.
- Bremelanotide (PT-141) — a peptide entry identified by the Bremelanotide and PT-141 names.
- FOXO4 D-Retro-Inverso Peptide (FOXO4-DRI) — fOXO4-DRI is a D-retro-inverso peptide associated with published FOXO4–p53 interaction research.
- Kisspeptin-10 (KP-10) — a short peptide fragment identified by the established Kisspeptin-10 designation.
- L-Carnitine — a small molecule commonly used in studies of acyl transport and mitochondrial metabolism.
- Lemon Bottle — a formulation-style catalogue entry whose composition is not established in the source record.
- Lipo-C — a formulation-style catalogue entry whose ingredient list and concentrations are not established in the source record.
- Melanotan I (MT-1) — a peptide entry commonly identified by the Melanotan I and MT-1 names.
- Melanotan II (MT-2) — a peptide entry commonly identified by the Melanotan II and MT-2 names.
- p53–Penetratin Chimeric Peptide (PNC-27) — pNC-27 is a p53–penetratin chimeric peptide identified by the PNC-27 designation.
- SLU-PP-332 — a synthetic small-molecule agonist reported in the literature for ERRα, ERRβ, and ERRγ research.
Tools, Guides & Comparisons
Use transparent calculators for research planning and record checks. Each tool has its own indexable page, formula explanation and input limits.
Peptide Reconstitution Calculator
Calculate solution concentration or required solvent volume from research inputs.
Peptide Blend Calculator
Model component concentrations and ratios for multi-compound laboratory mixtures.
Dilution & Serial Dilution Planner
Plan single-step and serial laboratory dilutions with transparent formulas.
Mass, Moles & Molarity Calculator
Convert between compound mass, molecular amount and solution molarity.
Peptide Unit Converter
Convert common mass, volume and concentration units used in research records.
Key Research Terms
These terms explain how identity, mechanism and evidence are presented across NOVABIO profiles.
- Identity
- The full name, abbreviation, development code and explicitly verified compound form.
- Mechanism
- The experimentally described target or pathway, separated from a clinical outcome claim.
- Evidence type
- Whether a record reports human, animal, in vitro, registry or mechanistic evidence.
- COA mapping
- A certificate linked to the exact product, strength and batch shown in the record.
How NOVABIO Builds Research Profiles
- Identify. Match names, abbreviations, codes and compound form.
- Source. Review official registries, peer-reviewed literature, chemical records, regulatory sources and batch documents.
- Separate. Label evidence type, limitations and the date each source was checked.
- Publish. Add a link only when compound-specific content supports a useful standalone page.
Last verified: 2026-10-06. Names remain unlinked until their complete Research Profiles are ready.
About the Peptide Research Library
What is included in a NOVABIO Research Profile?
A complete profile can include identity, aliases, targets, clinical records, published evidence, regulatory status, chemistry, research calculators and matched batch or COA records.
How are new profiles added?
NOVABIO adds a compound to this library only after its compound-specific Research Profile has been reviewed and published. New names and links are added as complete evidence pages become available.
Does this library provide medical or dosing guidance?
No. This library is for research and educational reference and does not provide human dosing, injection, cycle or treatment instructions.
USD